| Travis Baumann, MD | |
|
205 Parker St, Boscobel, WI 53805-1642 | |
| (608) 375-4112 | |
| Not Available |
| Full Name | Travis Baumann |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 205 Parker St, Boscobel, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134782584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 77289 (Wisconsin) | Secondary |
| 207Q00000X | Family Medicine | R-11421 (Iowa) | Secondary |
| 207Q00000X | Family Medicine | 77289 (Wisconsin) | Primary |
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
Stroke is a frequent and dreaded complication of atrial fibrillation. But predicting which of the estimated six million Americans with a-fib are at highest risk has long challenged physicians weighing stroke risk against the serious side effects posed by lifelong therapy with warfarin and other blood thinners.
Today we celebrate the 10th annual World Sleep Day. It is organized by the World Sleep Society, founded by the World Association of Sleep Medicine (WASM) and the World Sleep Federation (WSF), an international association whose mission is to advance sleep health worldwide.
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements for the European Society of Cardiology (ESC) Congress, which runs from August 29 to September 2 in Barcelona. Highlights include final results from the MADIT-CRT trial and two-year results from the SYNTAX trial.
Hepatitis C virus (HCV) infection affects about 4 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) agent in development for the treatment of HCV, targets one of the HCV proteins (i.e., NS5A) and causes the fastest viral decline (within 12 hours of treatment) ever seen with anti-HCV drugs.
› Verified 6 days ago
| Entity Name | Hancock County Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689721318 PECOS PAC ID: 9739080425 Enrollment ID: O20040115001023 |
News Archive
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
Stroke is a frequent and dreaded complication of atrial fibrillation. But predicting which of the estimated six million Americans with a-fib are at highest risk has long challenged physicians weighing stroke risk against the serious side effects posed by lifelong therapy with warfarin and other blood thinners.
Today we celebrate the 10th annual World Sleep Day. It is organized by the World Sleep Society, founded by the World Association of Sleep Medicine (WASM) and the World Sleep Federation (WSF), an international association whose mission is to advance sleep health worldwide.
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements for the European Society of Cardiology (ESC) Congress, which runs from August 29 to September 2 in Barcelona. Highlights include final results from the MADIT-CRT trial and two-year results from the SYNTAX trial.
Hepatitis C virus (HCV) infection affects about 4 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) agent in development for the treatment of HCV, targets one of the HCV proteins (i.e., NS5A) and causes the fastest viral decline (within 12 hours of treatment) ever seen with anti-HCV drugs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Travis Baumann, MD 515 22nd Ave, Monroe, WI 53566-1569 Ph: () - | Travis Baumann, MD 205 Parker St, Boscobel, WI 53805-1642 Ph: (608) 375-4112 |
News Archive
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
Stroke is a frequent and dreaded complication of atrial fibrillation. But predicting which of the estimated six million Americans with a-fib are at highest risk has long challenged physicians weighing stroke risk against the serious side effects posed by lifelong therapy with warfarin and other blood thinners.
Today we celebrate the 10th annual World Sleep Day. It is organized by the World Sleep Society, founded by the World Association of Sleep Medicine (WASM) and the World Sleep Federation (WSF), an international association whose mission is to advance sleep health worldwide.
Boston Scientific Corporation today announced the schedule of the Company's major events and news announcements for the European Society of Cardiology (ESC) Congress, which runs from August 29 to September 2 in Barcelona. Highlights include final results from the MADIT-CRT trial and two-year results from the SYNTAX trial.
Hepatitis C virus (HCV) infection affects about 4 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) agent in development for the treatment of HCV, targets one of the HCV proteins (i.e., NS5A) and causes the fastest viral decline (within 12 hours of treatment) ever seen with anti-HCV drugs.
› Verified 6 days ago
William P Fast, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 208 Parker St, Boscobel, WI 53805 Phone: 608-375-4144 Fax: 608-375-5629 | |
Dr. Burton Dale Cox Jr., DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 Morrison Dr, Hsu, Boscobel, WI 53805 Phone: 608-375-6433 Fax: 608-375-6439 | |
Kurt Wilhelm Ii, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 208 Parker St, Boscobel, WI 53805 Phone: 608-375-4144 Fax: 608-375-5629 | |
Dr. Colleen L Mccurry, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Parker St, Boscobel, WI 53805 Phone: 608-375-4112 | |
Justin Harrington, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 205 Parker St, Boscobel, WI 53805 Phone: 608-375-4112 | |
Marc L Wilkinson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Parker St, Boscobel, WI 53805 Phone: 608-375-4112 | |
Dr. Jennifer S Reink, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Parker St, Boscobel, WI 53805 Phone: 608-375-2424 |